CLC Bio LLC is a leading company based in Cambridge, MA, specializing in powerful digital solutions for scientific research and clinical testing. Their comprehensive range of products and services includes biomarker and target discovery, single-cell genomics, gene regulation, data and pipeline management, NGS variant assessment, and SARS-CoV-2 solutions. With their innovative technologies and expertise, CLC Bio LLC empowers researchers and clinical labs to make impactful discoveries and deliver patient-specific reports efficiently.
They offer a wide range of products, such as QIAGEN CLC Genomics Workbench, QIAGEN Ingenuity Pathway Analysis, and QIAGEN OmicSoft Suite, which provide interpretation, visualization, and analysis of genomic data. Additionally, their integrated omics databases, including QIAGEN DiseaseLand and QIAGEN OncoLand, offer valuable insights for researchers. With their commitment to quality and reliability, CLC Bio LLC is a trusted partner in the field of genomics and bioinformatics.
Generated from the website